Novartis AG (NOVN.S) has significantly increased its stockpiles of pharmaceuticals in the United States and is positioning itself to withstand...
Read moreThe White House confirmed a groundbreaking deal to keep TikTok’s American operations largely under US control, with Oracle stepping up...
Read moreIn a high-profile announcement coinciding with President Donald Trump’s state visit to Britain, US investment giant Blackstone pledged a staggering...
Read moreThe Donald Trump-led US government is about to cash in big from the long saga over TikTok’s American future.An exclusive...
Read moreSanta Clara-headquartered Oklo Inc (NYSE: OKLO) surged another 20% this morning – extending a blistering rally that now has the...
Read moreMorgan Stanley upgraded BB Seguridade (BBSE3) from underweight to equal-weight on Friday, following a steep correction in recent months. The...
Read morePony AI Inc (NASDAQ: PONY) rallied another 15% today after Leo Haojun, its chief of finance, said the robotaxi firm...
Read moreShares of educational publishing and media company Scholastic (NASDAQ: SCHL) fell sharply on Friday, dropping 13.6% after the company reported...
Read moreAGM Group Holdings Inc (NASDAQ: AGMH) stunned the market on Friday with a jaw-dropping 450% rally following a 6-K filing...
Read moreFriday evening saw a series of significant political, economic, and international developments. The US administration advanced a multibillion-dollar weapons package...
Read moreDisclaimer: EarningsMastery.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.